DeepEcho

Rabat, Morocco and Dover, Delaware, USA All United States companies → — Founded 2020

Imaging AI Specialist Specialty-Focused AI

Maternal-Fetal Medicine Obstetrics & Gynecology Radiology

OB/GYN AI Radiology & Imaging AI

Seed

Claim this company

Products

DEEPECHO

DeepEcho

OB/GYN AI

DeepEcho is an AI medical imaging company transforming fetal ultrasounds with AI-powered software that guides users through standardized probe sweeps and automatically generates measurements and diagnostic insights, mimicking the skill of a trained sonographer.

Contact for quote

See all 1 product →

About DeepEcho

DeepEcho is an AI-first health technology company dedicated to transforming prenatal care through advanced fetal ultrasound diagnostics. The company’s software leverages deep learning and computer vision to automate real-time identification of fetal ultrasound views, segment anatomical structures, and compute biometric measurements. This technology aims to enhance diagnostic accuracy and efficiency, particularly in settings where experienced sonographers are scarce, and to reduce operator variability. DeepEcho’s platform has demonstrated high precision, rivaling that of trained sonographers in fetal biometry and amniotic fluid volume assessment, with a peer-reviewed paper published in Nature Communications in November 2023.

DeepEcho’s mission is to democratize access to quality prenatal diagnosis globally, addressing critical challenges such as preventing birth defects, preterm birth, and low birth weight. Their AI-powered software is designed to be scalable, mobile, and hardware-agnostic, enabling minimally trained clinicians to perform accurate fetal assessments. The company has achieved significant milestones, including FDA 510(k) clearance in 2025 for its fetal ultrasound analysis platform and FDA Breakthrough Device Designation in March 2026 for its blind-sweep prenatal ultrasound platform. DeepEcho is also developing next-generation AI tools to identify novel biomarkers for earlier and more precise prediction of complex conditions like preeclampsia.

Focus Areas

AI in prenatal care fetal ultrasound maternal health diagnostic imaging deep learning computer vision medical AI

Business Intelligence

Technology

Cloud-native, deep learning algorithms, computer vision, hardware-agnostic software

What Physicians Need to Know

Specialization

DeepEcho specializes in AI-powered solutions for prenatal care, focusing on enhancing fetal ultrasound diagnostics and maternal health. They aim to prevent birth defects, address preterm birth, and low birth weight outcomes.

Key Differentiators

DeepEcho leverages one of the world's largest fetal ultrasound datasets, including a significant collection of African fetal ultrasound images, to train its advanced deep learning models. Their technology has achieved FDA 510(k) clearance for its fetal ultrasound analysis platform and FDA Breakthrough Device Designation. They offer solutions like 'Smart-Ruler' for accurate fetal measurements and 'BlindSweep' to guide untrained users through full scans.

Technology Stack

DeepEcho utilizes Artificial Intelligence and Deep Learning, specifically computer vision algorithms, to automate fetal ultrasound tasks. Their software is designed to be hardware-agnostic and mobile, enabling deployment in various healthcare settings. The technology includes automated fetal measurements, computer-assisted ultrasound diagnosis, and teleguidance for remote diagnosis.

Impact for Physicians

DeepEcho's solutions aim to make fetal ultrasound diagnostics faster (3 to 5 times), more accurate (over 95% accuracy), and more accessible. For trained sonographers, it acts as an efficiency tool, automating caliper placement and plane identification. For healthcare workers with limited training, it provides real-time guidance, enabling them to perform scans they otherwise couldn't. The technology helps reduce diagnostic variability and addresses the shortage of skilled radiologists, particularly in underserved regions.

Physician Tip

DeepEcho's platform can significantly enhance diagnostic accuracy and efficiency in fetal ultrasound. For experienced practitioners, it streamlines workflow by automating repetitive tasks like measurements and plane identification. For those with less experience or in resource-limited settings, the real-time guidance and 'BlindSweep' feature can empower them to conduct comprehensive and accurate scans, potentially reducing diagnostic delays and improving patient outcomes. The ability to identify novel biomarkers for conditions like preeclampsia also offers the potential for earlier intervention.

DeepEcho's software is designed to be hardware-agnostic and mobile, suggesting potential for integration with various ultrasound devices and existing healthcare IT infrastructures. They are also developing a lightweight mobile app with offline capabilities for use in areas with poor network coverage.

Products by DeepEcho

1 product in the directory

DEEPECHO

DeepEcho

OB/GYN AI

Contact for quote

What the Web Says

DeepEcho is an AI-first health technology company focused on revolutionizing prenatal care through AI-powered fetal ultrasound diagnostics. The company's platform aims to improve medical accuracy and quality diagnosis by automating fetal measurements and providing computer-assisted diagnostics, particularly in underserved international markets where access to prenatal imaging is limited. DeepEcho has achieved FDA 510(k) clearance for its fetal ultrasound analysis platform and has been recognized by TIME and Statista as one of the World's Top HealthTech Companies for 2025.

Overall: Positive

Strengths

AI-powered fetal imaging analysis and automated measurements.
Aims to democratize access to quality ultrasound globally.
Improves medical accuracy and quality diagnosis.
Reduces operator variability and streamlines workflow.
Fast screening (3 to 5x faster) and precise diagnosis (>95% accuracy).
Scalable solution that is mobile and hardware agnostic.

Limitations

Claims, figures, metrics, and scientific/marketing materials are not yet validated by the FDA (as of the website's disclaimer).
Clinical value varies by user expertise, acting as an efficiency tool for trained sonographers but providing real-time guidance for those with limited training.
No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit for "DeepEcho" as a company, only mentions in broader contexts or for different companies with similar names.

Based on reviews from: deepecho.io, natlawreview.com, reddit.com, facebook.com, stocktitan.net, femtechinsider.com, medstartr.ai, fool.com, biospace.com, wewillcure.com, capterra.com, g2.com

Last updated: 2026-10-29

Videos

News, demos, and interviews about DeepEcho.

Loading videos...

Videos load interactively. If none appear, search YouTube for DeepEcho →

View all on YouTube

Press & Coverage

deepecho.io

DeepEcho Expands Global Reach of AI-Powered Prenatal Ultrasound Through Butterfly Network Integration

DeepEcho announced the integration of its AI technology with Butterfly Network's handheld ultrasound platform, aiming to expand the global reach of AI-powered prenatal ultrasound, particularly in international markets where access to specialist imaging is limited. In the US, the integrated solution is currently available for training and educational purposes only.

2026-10

biospace.com

DeepEcho Receives FDA Breakthrough Device Designation for Blind Sweep Prenatal Ultrasound Platform

DeepEcho received Breakthrough Device Designation from the FDA for its DEEPECHO Blind Sweep Platform, which aims to make prenatal ultrasound more accessible by automating key measurements and guiding acquisition through software-driven analysis of B-mode ultrasound videos. This designation accelerates engagement with the FDA for technologies that offer substantial improvements in diagnosing serious conditions.

2026-03

medicaldevice-network.com

FDA clears DeepEcho's foetal ultrasound analysis platform

DeepEcho received 510(k) clearance from the FDA for its fetal ultrasound analysis platform, a significant step towards transforming prenatal care and democratizing access to quality fetal ultrasound. The AI solution uses deep learning to automate real-time identification of fetal ultrasound views, enhancing diagnostic accuracy and efficiency.

2025-06

femtechinsider.com

How Moroccan Startup DeepEcho Is Using AI to Democratize Fetal Ultrasound and Tackle Maternal Mortality

DeepEcho, a Moroccan AI healthtech company, has achieved FDA 510(k) clearance, published research in Nature Communications, and expanded operations across three continents, aiming to democratize fetal ultrasound and address maternal mortality. The company has raised $2.2 million to date from various investors.

2025-12

wewillcure.com

Deepecho's AI-driven Ultrasound Advances Maternal Healthcare

DeepEcho's AI-driven ultrasound tools are poised to transform healthcare in underserved regions globally by making fetal ultrasound accessible in low-resource environments. Their proprietary deep-learning models achieved world-first results in fetal biometry and amniotic fluid volume quantification, with precision rivaling trained sonographers.

2025-01

deepecho.io

DeepEcho : One of the World's Top HealthTech Companies of 2025 by TIME & Statista

DeepEcho was recognized by TIME & Statista as one of the World's Top HealthTech Companies of 2025.

2025-11

deepecho.io

DeepEcho and GUSI Partner to Advance Global Obstetric Ultrasound Education

DeepEcho partnered with GUSI to advance global obstetric ultrasound education.

2025-09

deepecho.io

DeepEcho's Research on Fetal Biometry and Amniotic Fluid Volume Automation Published in Nature Communications

DeepEcho's research on fetal biometry and amniotic fluid volume automation using Deep Learning was published in Nature Communications. The study highlighted how their models demonstrated superior consistency compared to human operators for key ultrasound tasks.

2023-11

Frequently Asked Questions

What specific AI products does DeepEcho offer for prenatal care and fetal ultrasound?

DeepEcho offers an AI-powered fetal ultrasound analysis platform that automates real-time identification of fetal ultrasound views, enhancing diagnostic accuracy and efficiency. Their platform includes 'Smart-Ruler' for accurate fetal measurements from short ultrasound loops and 'BlindSweep,' a protocol that guides even untrained users through a full scan. These tools aim to standardize image acquisition and analysis, including fetal biometry and amniotic fluid volume assessment.

How does DeepEcho ensure compliance and regulatory approval for its medical AI solutions?

DeepEcho has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its fetal ultrasound analysis platform, a significant step for its prenatal care mission. Additionally, their DEEPECHO Blind Sweep Platform has been granted FDA Breakthrough Device Designation, which may accelerate its development and regulatory review process. The company emphasizes that its technology is built by physicians, AI scientists, and imaging experts to address clinical challenges and ensure quality and safety.

What is DeepEcho's pricing model for its AI solutions, and how does it compare to traditional methods?

While specific pricing details are not publicly disclosed, DeepEcho's technology is designed to be cost-effective and scalable, aiming to reduce the time and cost of care. Their solutions are intended to make fetal ultrasound accessible in low-resource environments and to address healthcare access challenges by enabling minimally trained clinicians to perform accurate fetal assessments. This approach suggests a focus on affordability and broader accessibility compared to traditional methods that rely heavily on highly specialized sonographers.

What kind of support and training does DeepEcho provide to healthcare professionals using its AI platform?

DeepEcho's AI platform is designed to assist both trained sonographers and minimally trained clinicians. For experienced sonographers, it acts as an efficiency tool by automating caliper placement and plane identification. For healthcare workers with limited training, it provides real-time guidance to enable them to perform scans they might not otherwise attempt. DeepEcho has also partnered with the Global Ultrasound Institute (GUSI) to advance Point-of-Care Ultrasound (POCUS) education, integrating DeepEcho's AI into GUSI's OB-focused training programs.

What partnerships does DeepEcho have, and how do they contribute to the company's offerings and stability?

DeepEcho has established several key partnerships. They have integrated their AI technology with Butterfly Network's handheld ultrasound platform to expand prenatal ultrasound beyond specialist clinics. They also collaborate with the Global Ultrasound Institute (GUSI) to enhance obstetric ultrasound education. DeepEcho is supported by various organizations, including Microsoft, Nvidia, Plug and Play, UM6P, Orange, and the European Bank. These partnerships contribute to the company's technological development, market reach, and overall stability.

What is the current stability of DeepEcho as a company, including its funding and growth trajectory?

DeepEcho was founded in 2020 and is headquartered in Rabat, Morocco, with offices across the U.S., Europe, and Africa. The company has raised funding from investors such as Plug and Play, UM6P Ventures, Al Mada Ventures, Algebra Ventures, and has received grants from organizations like the Bill & Melinda Gates Foundation and the GSMA Innovation Fund. DeepEcho has achieved FDA 510(k) clearance and Breakthrough Device Designation, indicating significant regulatory progress and a strong growth trajectory in the medical AI space.

How does DeepEcho address concerns about AI in medical diagnostics, particularly regarding accuracy and physician oversight?

DeepEcho's AI software aims for high accuracy, facilitating greater than 95% accuracy in fetal ultrasound evaluations through automated segmentation and suggested measurements. The company emphasizes that its products are developed by doctors and AI scientists, leveraging deep learning and computer vision to mimic the skills of a trained sonographer. While the AI assists in image acquisition and measurements, the system is designed for trained healthcare personnel to acquire scans, with licensed clinicians remaining responsible for interpretation and diagnosis, ensuring physician oversight.

Related Companies

Suggest an Edit → | Report an issue